BioSpace News Archive

Deals

ZAP Surgical Announces US$81 Million Financing Round

Funds Will Be Used to Accelerate Commercialization of the ZAP-X Robotic Surgical Platform for Non-Invasive Treatment of Brain Tumors Affecting More Than 2 Million Cancer Patients Worldwide

January 8, 2020
·
3 min read
Deals

Esteve acquires German proprietary, specialty, hospital-focused company Riemser and expands its presence in Europe

The acquisition provides Esteve with greater pharmaceutical presence in Europe’s main markets and a portfolio of proprietary specialty products for hospital use.

January 8, 2020
·
2 min read
Deals

NorthSea Therapeutics Announces US $40 Million Series B Financing to Complete Phase IIb ICONA study in NASH and to Advance Two Additional SEFAs into the Clinic

NorthSea Therapeutics B.V. announced the closing of a US $40 million Series B financing round.

January 8, 2020
·
8 min read
Drug Development

TLC Announces Dosing of First Patients in Part 2 of TLC590 Phase II Trial for Postsurgical Pain following Bunionectomy

TLC announced that the first batch of patients has been dosed in Part 2 of the Phase II clinical trial for TLC590 in patients following bunionectomy surgery.

January 8, 2020
·
5 min read
Biotech Beach

Edwards Lifesciences To Present At The 38th Annual J.P. Morgan Healthcare Conference

Edwards Lifesciences Corporation, the global leader in patient-focused innovations for structural heart disease and critical care monitoring, is scheduled to present at the J.P. Morgan Healthcare Conference at the Westin St. Francis in San Francisco on Monday, January 13, 2020.

January 8, 2020
·
1 min read
Global Hepatitis C Drugs Market 2019-2023 | Evolving Opportunities with AbbVie and Gilead | Technavio

Technavio has announced its latest market research report titled global hepatitis C drugs market 2019-2023.

January 8, 2020
·
4 min read
Deals

Bright Health to Expand into California through Planned Acquisition of Brand New Day Health Plan

Bright Health, a diversified consumer-focused healthcare company, announced it has signed an agreement to acquire California-based Universal Care health plan.

January 8, 2020
·
3 min read
Policy

Finch Therapeutics Completes Enrollment in Potentially Pivotal Trial of CP101, an Investigational Oral Full-Spectrum Microbiota® Therapy for the Prevention of Recurrent C. difficile Infection

Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, announced that it has completed enrollment in PRISM3, its multi-center, placebo-controlled Phase 2 clinical trial evaluating CP101.

January 8, 2020
·
5 min read
Policy

In New National Poll, Veterinarians Report That FDA’s Proposed Guidance Will Have a Significant Negative Impact on Animal Patients

A new nationwide poll of veterinary practices confirms that new guidance proposed by the Food & Drug Administration would have a significant negative impact on their practices and their patients’ health if issued and enforced.

January 8, 2020
·
5 min read
ProMIS Neurosciences issues Chairman’s Update detailing positive outlook for Alzheimer’s disease therapy, pipeline in 2020

Anticipated approval of first amyloid-beta-targeting therapy to pave the way for next-generation therapies; PMN310 positioned as best-in-class against amyloid toxicity

January 8, 2020
·
4 min read